A detailed history of New York State Common Retirement Fund transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 37,235 shares of MRSN stock, worth $93,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,235
Previous 37,235 -0.0%
Holding current value
$93,832
Previous $75,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$2.0 - $4.45 $160 - $356
80 Added 0.22%
37,235 $75,000
Q1 2024

May 07, 2024

SELL
$2.16 - $5.94 $203 - $558
-94 Reduced 0.25%
37,155 $166,000
Q4 2023

Feb 01, 2024

SELL
$1.11 - $2.34 $118 - $250
-107 Reduced 0.29%
37,249 $86,000
Q3 2023

Nov 07, 2023

BUY
$1.06 - $3.91 $384 - $1,419
363 Added 0.98%
37,356 $47,000
Q2 2023

Aug 07, 2023

SELL
$3.08 - $9.55 $354 - $1,098
-115 Reduced 0.31%
36,993 $122,000
Q1 2023

May 02, 2023

SELL
$4.0 - $7.02 $75,492 - $132,488
-18,873 Reduced 33.71%
37,108 $153,000
Q4 2022

Jan 30, 2023

SELL
$5.65 - $7.86 $113 - $157
-20 Reduced 0.04%
55,981 $328,000
Q3 2022

Nov 08, 2022

BUY
$4.63 - $8.0 $33,780 - $58,368
7,296 Added 14.98%
56,001 $379,000
Q2 2022

Aug 04, 2022

SELL
$2.84 - $5.0 $335 - $590
-118 Reduced 0.24%
48,705 $225,000
Q1 2022

May 05, 2022

SELL
$3.74 - $6.63 $11,163 - $19,790
-2,985 Reduced 5.76%
48,823 $195,000
Q4 2021

Feb 02, 2022

SELL
$5.48 - $9.86 $306 - $552
-56 Reduced 0.11%
51,808 $322,000
Q3 2021

Nov 02, 2021

SELL
$8.56 - $14.47 $64,893 - $109,697
-7,581 Reduced 12.75%
51,864 $489,000
Q2 2021

Aug 02, 2021

BUY
$13.28 - $18.07 $148,005 - $201,390
11,145 Added 23.07%
59,445 $807,000
Q4 2020

Feb 08, 2021

BUY
$16.84 - $27.59 $106,092 - $173,817
6,300 Added 15.0%
48,300 $1.29 Million
Q2 2020

Aug 07, 2020

BUY
$5.24 - $23.4 $79,648 - $355,680
15,200 Added 56.72%
42,000 $983,000
Q1 2020

May 06, 2020

BUY
$4.41 - $9.28 $66,591 - $140,128
15,100 Added 129.06%
26,800 $156,000
Q3 2019

Nov 07, 2019

SELL
$1.54 - $4.2 $38,500 - $105,000
-25,000 Reduced 68.12%
11,700 $18,000
Q2 2019

Aug 09, 2019

BUY
$3.84 - $6.4 $94,464 - $157,440
24,600 Added 203.31%
36,700 $149,000
Q1 2018

May 10, 2018

BUY
$13.56 - $18.48 $119,328 - $162,624
8,800 Added 266.67%
12,100 $191,000
Q4 2017

Feb 13, 2018

BUY
$14.95 - $19.9 $34,385 - $45,770
2,300 Added 230.0%
3,300 $54,000
Q3 2017

Nov 06, 2017

BUY
$14.8 - $18.06 $14,800 - $18,060
1,000
1,000 $17,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $245M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.